Our daily roundup of the science presented at the 2018 HD Therapeutics Conference in Palm Springs
Pfizer announces the 'Amaryllis' trial of a PDE-10 inhibitor drug failed to improve symptoms of HD
HDBuzz summarizes the science from an unusually large and energized @HDSA convention in Baltimore
A new biomarker reveals brain changes in early Huntington's disease.